COMPOSITE EPIGENETIC BIOMARKERS FOR ACCURATE SCREENING, DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER

摘要

The present disclosure concerns particular biomarkers for screening, diagnosing and/or prognosticating colorectal cancer, in particular in an accurate manner. The methods and compositions concern analysis of methylation patterns of one or more of 176 methylatable genomic DNA regions identified as described herein. In particular embodiments there are methods of detecting methylatable regions in genomic sequences.